Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up

Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up

We sought to assess the efficacy of combining onabotulinumtoxinA (BoNTA) as add-on therapy to carbamazepine or oxcarbazepine in treatment-refractory patients with trigeminal neuralgia (TGN) who failed to respond (less than 30% response rate) to adequate monotherapy. We conducted a retrospective stud...

Full description

Bibliographic Details
Main Authors: Georgia Xiromerisiou, Ioannis C. Lampropoulos, Emmanouil V. Dermitzakis, Michail Vikelis, Chrysoula Marogianni, Dimitrios Mysiris, Andreas A. Argyriou
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Toxins
Subjects:
neuropathic pain
treatment-refractory trigeminal neuralgia
onabotulinumtoxinA
symptomatic therapy
Online Access:https://www.mdpi.com/2072-6651/15/9/539

Similar Items

Similar Items